Ahmer Zaeema
APPNA Institute of Public Health, Jinnah Sindh Medical University, Karachi, Pakistan.
J Pak Med Assoc. 2024 Nov;74(11 (Supple-12)):S44-S46. doi: 10.47391/JPMA.AKU-EPP-09.
The relationship between physicians and the pharmaceutical industry has evolved significantly over the years, raising concerns about ethical practices in medical prescribing. This article explores the multifaceted influence of pharmaceutical companies on physician behaviour, highlighting how marketing strategies, financial incentives, and promotional activities can compromise the integrity of clinical decision-making. Through a comprehensive review of the literature, the article examines the implications of inculcating ethics in undergraduate medical programmes, so future healthcare professionals understand the importance of making evidence-based decisions. Furthermore, this article calls for a critical evaluation of existing regulatory frameworks and advocates for stronger ethical guidelines to ensure that physician prescriptions are based solely on patient needs rather than external pressures from the pharmaceutical industry. Ultimately, it emphasizes the importance of restoring ethical standards in medicine to safeguard patient welfare and maintain the sanctity of the physician-patient relationship.
多年来，医生与制药行业之间的关系发生了显著变化，这引发了人们对医疗处方中道德行为的担忧。本文探讨了制药公司对医生行为的多方面影响，强调了营销策略、经济激励和促销活动如何可能损害临床决策的公正性。通过对文献的全面回顾，本文审视了在本科医学课程中灌输道德观念的意义，以便未来的医疗保健专业人员理解基于证据做出决策的重要性。此外，本文呼吁对现有监管框架进行批判性评估，并倡导制定更强有力的道德准则，以确保医生的处方完全基于患者需求，而非制药行业的外部压力。最终，它强调了恢复医学道德标准对于保障患者福祉和维护医患关系神圣性的重要性。
